Attovia Therapeutics, Inc.

NASDAQ: ATTO · Healthcare · Biotechnology

PublicHQ San Carlos, CA · San MateoCIK 0002058707Reports USD

#1 of 1,417 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS —

v0.1 · 0/100 weight · pillars only

↑ listing tenure · ↓ listing tenure

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

as of 2026-08-18

Market cap

—

as of 2026-08-18

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Attovia Therapeutics, Inc.’s financial profile?

Attovia Therapeutics, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

BodyScan Corp.——Antigenics, Inc.——Apnimed, Inc.——BlossomHill Therapeutics, Inc.——Vogenx Inc.——LifePoint, Inc.——

Neighbors

San Mateo →

Meta Platforms, Inc.$201.0B86A Gilead Sciences, Inc.$29.4B87A Equinix, Inc.$9.2B74B Robinhood Markets, Inc.$4.5B67B Electronic Arts Inc.$7.5B82B+Revolution Medicines, Inc.$052D

Key facts

CEOTao Fu

SectorHealthcare

IndustryBiotechnology

HeadquartersSan Carlos, CA

ExchangeNASDAQ: ATTO

Employees—

IPO date2026-08-05

Latest filings

8-K2026-08-06

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.